ID: ALA1643107

Max Phase: Preclinical

Molecular Formula: C18H15BrO4

Molecular Weight: 375.22

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1ccc2c(=O)c(-c3ccc(OCCBr)cc3)coc2c1

Standard InChI:  InChI=1S/C18H15BrO4/c1-21-14-6-7-15-17(10-14)23-11-16(18(15)20)12-2-4-13(5-3-12)22-9-8-19/h2-7,10-11H,8-9H2,1H3

Standard InChI Key:  VUMZUBQNZGDXKB-UHFFFAOYSA-N

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 375.22Molecular Weight (Monoisotopic): 374.0154AlogP: 4.24#Rotatable Bonds: 5
Polar Surface Area: 48.67Molecular Species: NEUTRALHBA: 4HBD: 0
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 3.87CX LogD: 3.87
Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.63Np Likeness Score: 0.12

References

1. Yadav DK, Gautam AK, Kureel J, Srivastava K, Sahai M, Singh D, Chattopadhyay N, Maurya R..  (2011)  Synthetic analogs of daidzein, having more potent osteoblast stimulating effect.,  21  (2): [PMID:21194940] [10.1016/j.bmcl.2010.12.008]

Source